In the last 30 years there has been very little change to osteosarcoma (OS) treatment. We are dedicated to changing this. Through the Myrovlytis Trust, we fund research into OS, with a focus on finding new treatments. We are pleased to announce we have awarded funding...

Welcome to the ONTEX social media toolkit. We are delighted to have launched our new improved Osteosarcoma Now Trial EXplorer (ONTEX). Each osteosarcoma clinical trial has been summarised to give a clear picture of its aims, what it involves and who can take part. Its...

We are delighted to launch our new improved Osteosarcoma Now Trial EXplorer (ONTEX). ONTEX is an international database that aims to make clinical trial information available and accessible to all. Each osteosarcoma clinical trial has been summarised to give a clear...

Our work in osteosarcoma started in 2021, with many months dedicated to talking with experts, patients and other charities. In this blog we reflect on what we achieved in 2022.

Hello Everyone. We are closed from Friday 23rd December until Tuesday 3rd January. During that time all the content on the website will be available but we will be taking a break from the weekly blogs. On our return, we will respond to any emails. From all of us at...

Sign up for the Osteosarcoma Now Newsletter. Each issue will discuss the current research and signpost to events across the world.

We attended the 2022 CTOS annual meeting. The meeting brought together clinicians, researchers and patient advocates dedicated to improving outcomes in sarcoma.

Surgeons may remove bone containing osteosarcoma and replace it with a metal implant. A study looked at whether carbon-fibre could be an alternative to metal.

There is an urgent need to find new therapies in osteosarcoma (OS) that has spread or has not responded to standard treatment. Identifying new treatments can be a long and complex process. One method of speeding up the process is to use drugs that already approved to...

There is a great need to develop new treatments for osteosarcoma (OS). This is particularly true for OS that has spread or has not responded to current standard therapy. Researchers are actively working towards finding new drugs to treat OS. To enable the drug...